ANDA 85995, held by Hospira. Lidocaine Hydrochloride.
As of Nov 16, 2026, ANDA 85995 (Pediatric Lta Kit), held by Hospira, was first approved by FDA on Nov 17, 1977, with 7 approved supplements and 0 published complete response letters.
| Date | Submission | Status | Documents |
|---|---|---|---|
| Nov 17, 1977 | Original application | Approved | None posted |
| Product | Active ingredient | Marketing |
|---|---|---|
| Pediatric Lta Kit2% ยท solution;topical | Lidocaine Hydrochloride | Discontinued |
| May 4, 1993 | Supplement 16Labeling | Approved | None posted |
| Jun 30, 1989 | Supplement 15Labeling | Approved | None posted |
| Mar 20, 1989 | Supplement 14Manufacturing | Approved | None posted |
| Aug 15, 1986 | Supplement 13Manufacturing | Approved | None posted |
| Apr 17, 1985 | Supplement 12Manufacturing | Approved | None posted |
| Jul 13, 1983 | Supplement 11Manufacturing | Approved | None posted |
| Jan 28, 1983 | Supplement 9Manufacturing | Approved | None posted |
| Nov 17, 1977 | Original application | Approved | None posted |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters